Anne-Lise Gérard

Anne-Lise Gérard

Auto-generated profile, based on publicly available information

Anne-Lise Gérard

School of Life and Environmental Sciences Deakin University Waurn Ponds Australia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in iScience
Verified
Journal Article
Open access
JBJustine Boutry
Justine Boutry
ADAntoine Dujon
Antoine Dujon
AGAnne-Lise Gerard
Anne-Lise Gerard
STSophie Tissot
Sophie Tissot
NMNick Macdonald
Nick Macdonald
Frederic ThomasFrederic Thomas
Frederic Thomas
Cellular cheating leading to cancers exists in all branches of multicellular life, favoring the evolution of adaptations to avoid or suppress malignant progression, and/or to alleviate its fitness consequences. Ecologists have until recently largely neglected the importance of cancer cells for animal ecology, presumably because they did not consider either the potential ecological or evolutionary consequences of anticancer adaptations. Here, we review the diverse ways in which the evolution of anticancer adaptations has significantly constrained several aspects of the evolutionary ecology of multicellular organisms at the cell, individual, population, species, and ecosystem levels and suggest some avenues for future research.

12 February 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
STSophie Tissot
Sophie Tissot
AGAnne-Lise Gérard
Anne-Lise Gérard
JBJustine Boutry
Justine Boutry
ADAntoine Dujon
Antoine Dujon
TRTracey Russel
Tracey Russel
Frederic ThomasFrederic Thomas
Frederic Thomas
Although the true prevalence of transmissible cancers is not known, these atypical malignancies are likely rare in the wild. The reasons behind this rarity are only partially understood, but the “Perfect Storm hypothesis” suggests that transmissible cancers are infrequent because a precise confluence of tumor and host traits is required for their emergence. This explanation is plausible as transmissible cancers, like all emerging pathogens, will need specific biotic and abiotic conditions to be able to not only emerge, but to spread to detectable levels. Because those conditions would be rarely met, transmissible cancers would rarely spread, and thus most of the time disappear, even though they would regularly appear. Thus, further research is needed to identify the most important factors that can facilitate or block the emergence of transmissible cancers and influence their evolution. Such investigations are particularly relevant given that human activities are increasingly encroaching into wild areas, altering ecosystems and their processes, which can influence the conditions needed for the emergence and spread of transmissible cell lines.

10 March 2024 in Evolutionary Applications
Verified
Journal Article
Open access
PDF file
AGAnne‐Lise Gérard
Anne‐Lise Gérard
RORachel S. Owen
Rachel S. Owen
ADAntoine M. Dujon
Antoine M. Dujon
BRBenjamin Roche
Benjamin Roche
RHRodrigo Hamede
Rodrigo Hamede
HSHannah V Siddle
Hannah V Siddle
Since the emergence of a transmissible cancer, devil facial tumour disease (DFT1), in the 1980s, wild Tasmanian devil populations have been in decline. In 2016, a second, independently evolved transmissible cancer (DFT2) was discovered raising concerns for survival of the host species. Here, we applied experimental and modelling frameworks to examine competition dynamics between the two transmissible cancers in vitro. Using representative cell lines for DFT1 and DFT2, we have found that in monoculture, DFT2 grows twice as fast as DFT1 but reaches lower maximum cell densities. Using co‐cultures, we demonstrate that DFT2 outcompetes DFT1: the number of DFT1 cells decreasing over time, never reaching exponential growth. This phenomenon could not be replicated when cells were grown separated by a semi‐permeable membrane, consistent with exertion of mechanical stress on DFT1 cells by DFT2. A logistic model and a Lotka–Volterra competition model were used to interrogate monoculture and co‐culture growth curves, respectively, suggesting DFT2 is a better competitor than DFT1, but also showing that competition outcomes might depend on the initial number of cells, at least in the laboratory. We provide theories how the in vitro results could be translated to observations in the wild and propose that these results may indicate that although DFT2 is currently in a smaller geographic area than DFT1, it could have the potential to outcompete DFT1. Furthermore, we provide a framework for improving the parameterization of epidemiological models applied to these cancer lineages, which will inform future disease management.

14 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAnne-Lise Gérard
Anne-Lise Gérard
FPFlorence Pirard
Florence Pirard
CVCaitlin Vanbeek
Caitlin Vanbeek
ADAntoine Dujon
Antoine Dujon
ASAaron G. Schultz
Aaron G. Schultz
BUBeata Ujvari
Beata Ujvari
Devil Facial Tumour Diseases (DFTD), threatening Tasmanian devils, consist of two distinct transmissible cancers, DFT1 and DFT2, with differing origins and geographic spread. We investigated the metabolic differences between DFT1 and DFT2, examining cell viability, metabolic outputs, and bulk gene expression. Using both DFT1 and DFT2 cell lines and biopsies, we found that glycolysis, oxidative phosphorylation, glutamate metabolism and fatty acid synthesis are all essential for the survival of both tumour types. However, DFT2 exhibited higher rates of glycolysis and lactate generation compared to DFT1. This coincided with elevated ATP production, cholesterol biosynthesis and ROS generation, as well as an increased reliance on fatty acid metabolism. Furthermore, DFT2 is less metabolically adaptable than DFT1, being unable to switch to oxidative phosphorylation as DFT1 can when required. These metabolic changes in DFT2, in conjunction with its higher growth rate, suggests a more aggressive cancer phenotype than DFT1. Our findings highlight distinct metabolic adaptations in DFT2 that may contribute to its competitive advantage.

29 January 2026 in The FEBS Journal
Verified
Journal Article
Closed access
AGAnne‐Lise Gérard
Anne‐Lise Gérard
FPFlorence Pirard
Florence Pirard
CVCaitlin Vanbeek
Caitlin Vanbeek
ADAntoine Dujon
Antoine Dujon
ASAaron Schultz
Aaron Schultz
BUBeata Ujvari
Beata Ujvari